Vanrx customers are dispersed across several countries spanning four continents.
A number of our customers have publicly announced or presented on their use of Vanrx Workcells. These companies include: Adaptive Phage Therapeutics, Amgen, Emergent BioSolutions, FUJIFILM Diosynth Biotechnologies, Moderna Therapeutics, Patheon, Roche / Genentech, Singota Solutions, Wildlife Pharmaceuticals and WuXi Biologics.
Vanrx customers are building filling capacity faster and are prepared for whatever comes down the pipeline. But don’t take our word for it — see for yourself.
Moderna Therapeutics is using a Vanrx SA25 Aseptic Filling Workcell at its Norwood, Massachusetts site for clinical trial supply manufacturing and product development.
On November 6, 2018, Dr. Nitin Rathore, Director of Process Development at Amgen, presented 'Implementation of Next-Generation Technologies in Biomanufacturing' at the American Association of Pharmaceutical Scientists (AAPS) Pharma 360 conference in Washington, D.C.Read More
On November 6 at AAPS, Markus Stübchen, Roche’s Global Technical Lead for Large Molecule Drug Product & Clean Utilities, delivered the presentation Novel Approaches for Robotics Use in Sterile Manufacturing. The presentation described how Roche / Genentech will use Vanrx's SA25 as part of a "network" strategy.Read More
How Aseptic Filling Workcells will change your operations.
A "big picture" look at manufacturing strategies for speed to market and flexibility.
Highly agile technologies for filling of personalized medicines like cell and gene therapies.
Adaptive Phage Therapeutics (APT) is developing PhageBank, a collection of viruses to kill the most dangerous antibiotic resistant superbugs. Their challenge is to fill multiple viruses every day in building a library of 1,000+ drug products. APT needed a highly agile vial filling system and chose Vanrx’s Microcell Vial Filler to accelerate the process.
Singota Solutions recognized a gap in the market for contract aseptic filling services. They realized that companies developing new drug products and needing to fill batches of 20,000 units or less were underserved by contract manufacturing organizations. They chose Vanrx’s SA25 Aseptic Filling Workcell to provide an agile filling service for vials, syringes and cartridges, with short lead times.Read the case study
In aseptic processing, people are the primary source of contamination. Less human contact during manufacturing means less risk of contamination. To address this issue, Patheon successfully implemented a robotic filling line that operates in a closed isolator environment with no glove ports. This case study takes a look at the technology involved and highlights the implementation team’s experience with installation and qualification.Read the case study
Fujifilm Diosynth has expanded its fill/finish capabilities for late stage and commercial gene therapies and viral vaccines using Vanrx's SA25 Aseptic Filling Workcell. The SA25 will be installed at Fujifilm’s biomanufacturing facility in College Station, Texas.Read More
Injectable biologics are growing to focus on small batches of more personalized medicines. Wildlife Pharmaceuticals accepted this change and opted for a small, highly specialized and controlled facility to specifically address their needs. They chose the SA25 Aseptic Filling Workcell. This case study takes a look at Wildlife pharmaceuticals decision process and customer testimonial.Read the case study
View detailed product information, benefits and specifications.
From PO to fully qualified in 6 months or less
From order to installation and validation in 12 months
Flexibly produce either liquid or lyophilized dosages.